Purines
This graph shows the total number of publications written about "Purines" by people in the URMC Research Network by year, and whether "Purines" was a major or minor topic of these publication.
Below are the most recent publications written about "Purines" by people in Profiles.
-
LeWitt P, Schultz L, Auinger P, Lu M. CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease. Brain Res. 2011 Aug 23; 1408:88-97.
-
Levin YD, White RJ. Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil. Drugs Today (Barc). 2011 Feb; 47(2):145-56.
-
Gerich J. DPP-4 inhibitors: what may be the clinical differentiators? Diabetes Res Clin Pract. 2010 Nov; 90(2):131-40.
-
Yarotskyy V, Elmslie KS. Interference between two modulators of N-type (CaV2.2) calcium channel gating demonstrates that omega-conotoxin GVIA disrupts open state gating. Biochim Biophys Acta. 2010 Sep; 1798(9):1821-8.
-
Yarotskyy V, Elmslie KS. Open-state occupancy prevents gating charge relaxation of N-type (CaV2.2) calcium channels. Biophys J. 2009 Nov 4; 97(9):2446-55.
-
Yarotskyy V, Gao G, Du L, Ganapathi SB, Peterson BZ, Elmslie KS. Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation. J Biol Chem. 2010 Jan 1; 285(1):43-53.
-
Gough MS, White RJ. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension. Liver Transpl. 2009 Jan; 15(1):30-6.
-
Yarotskyy V, Gao G, Peterson BZ, Elmslie KS. The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation. J Physiol. 2009 Feb 1; 587(Pt 3):551-65.
-
Shakespeare WC, Wang Y, Bohacek R, Keenan T, Sundaramoorthi R, Metcalf C, Dilauro A, Roeloffzen S, Liu S, Saltmarsh J, Paramanathan G, Dalgarno D, Narula S, Pradeepan S, van Schravendijk MR, Keats J, Ram M, Liou S, Adams S, Wardwell S, Bogus J, Iuliucci J, Weigele M, Xing L, Boyce B, Sawyer TK. SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activity. Chem Biol Drug Des. 2008 Feb; 71(2):97-105.
-
Nadtochiy SM, Nauduri D, Shimanskaya TV, Sagach VF, Brookes PS. Purine release: a protective signaling mechanism of the mitochondrial permeability transition pore in ischemia. Fiziol Zh. 2008; 54(6):5-14.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
